There’s a revolutionary new tech being hailed as “one of the largest disruptions in history”, and it will be known to “define the next decade”.
Packed into a tiny capsule is a technology that will reshape human history more than the atom bomb, the combustion engine, and the electric lightbulb combined.
This technological breakthrough is poised to generate up to $15 trillion in new wealth over the next five years…
And one tiny Brisbane company has virtually monopolized this technology with 140 foolproof patents.
This compound has already passed preclinical trials with flying colors and is about to enter the final phase of trials for the first time.
When a company passes trial, it’s almost guaranteed to make it to market, which usually sends the company’s share price soaring.
Take a look at shares for these biotech companies after their successful trials:
- Aquinox’s stock exploded to $55.75 a share, handing investors a 3,278% return in a single day.
- Reata Pharmaceuticals’ share price climbed from $46.60 to $76.55 in a single day, and it hit $92.06 three months after.
- Amarin Corporation’s shares climbed from $2.99 to $12.40 in a single day, with a gain of 314%. Within 30 days, the stock had climbed to $22.98, returning 669%. Investors could have turned $2,500 into $19,220 in less than a month!
For those investors who wait until early-stage results are announced to place their stakes, it will be too late… The stock will already be skyrocketing upward, and they’ll be left chewing dust as someone else takes their profits.
Right now, it still trades for $5.
That’s why investors have to get in before positive trial results are revealed just a few short weeks from now.
Enter your email for a report containing the name & ticker symbol of this innovative company.
By submitting your email address, you give Todays Top Picks permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time To review our privacy policy, click here: Privacy Policy | How it Works
